| 注册
首页|期刊导航|重庆医学|乳腺癌 GPR30、HRG1和 HER2表达与淋巴结转移关系的研究

乳腺癌 GPR30、HRG1和 HER2表达与淋巴结转移关系的研究

阮姝琴 李刚 王善伟 韩萍 杨志祥

重庆医学Issue(7):878-880,3.
重庆医学Issue(7):878-880,3.DOI:10.3969/j.issn.1671-8348.2015.07.005

乳腺癌 GPR30、HRG1和 HER2表达与淋巴结转移关系的研究

Expression of GPR30,HRG1 and HER2 in breast cancer and their relationship with lymphatic metastasis

阮姝琴 1李刚 2王善伟 3韩萍 4杨志祥1

作者信息

  • 1. 重庆市中山医院肿瘤血液科 400012
  • 2. 重庆市中山医院病理科 400012
  • 3. 浙江大学肿瘤研究所,杭州 310009
  • 4. 西安医学院病理教研室,陕西 710021
  • 折叠

摘要

Abstract

Objective To explore the expression of GPR30,HRG1 and HER2 including the activation status of HER2 (phosphorylated HER2)in invasive ductal breast cancers and their relationship with lymphatic metastasis.Methods The expres-sion of GPR30,HRG1,HER2 and pHER2 in 72 cases of specimens of invasive ductal breast cancers were examined by immunohis-tochemistry method.Results A moderate correlation between GPR30 and HRG1 was disclosed (r=0.597,P =0.000).There was strong correlation between pHER2 and GPR30 or HRG1(r=0.742,P =0.000;r=0.615,P =0.000).The expression of GPR30 and pHER2 in the lymphatic metastasis group was remarkably higher than in the group without lymphatic metastasis(P <0.05). Conclusion The interaction between GPR30 and HRG1 HER2 signal transduction pathways might be involved in the lymphatic metastasis in breast cancer.Blocking both of GPR30 and HRG1 signaling pathway could be a promising new strategy for breast cancer treatments.

关键词

乳腺肿瘤/淋巴转移/G蛋白偶联受体30/HRG1/HER2

Key words

breast neoplasms/lymphatic metastasis/GPR30/HRG1/HER2

分类

医药卫生

引用本文复制引用

阮姝琴,李刚,王善伟,韩萍,杨志祥..乳腺癌 GPR30、HRG1和 HER2表达与淋巴结转移关系的研究[J].重庆医学,2015,(7):878-880,3.

基金项目

重庆市卫生局医学科研项目(2013-2-111);陕西省教育厅自然科学研究项目(12JK0709)。 ()

重庆医学

OA北大核心CSTPCD

1671-8348

访问量5
|
下载量0
段落导航相关论文